Eltrombopag in long‐term management of pediatric thrombocytopenia

Eltrombopag is a thrombopoietin receptor agonist that may be effective in a broad range of thrombocytopenias of distinct etiology. We have observed rapid, robust, and sustained responses to eltrombopag in two young patients with refractory thrombocytopenia, one with primary immune thrombocytopenia a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Sanjay J., Etzl, Michael M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333124/
https://www.ncbi.nlm.nih.gov/pubmed/30656041
http://dx.doi.org/10.1002/ccr3.1916
_version_ 1783387505157996544
author Shah, Sanjay J.
Etzl, Michael M.
author_facet Shah, Sanjay J.
Etzl, Michael M.
author_sort Shah, Sanjay J.
collection PubMed
description Eltrombopag is a thrombopoietin receptor agonist that may be effective in a broad range of thrombocytopenias of distinct etiology. We have observed rapid, robust, and sustained responses to eltrombopag in two young patients with refractory thrombocytopenia, one with primary immune thrombocytopenia and the other with Evans syndrome.
format Online
Article
Text
id pubmed-6333124
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63331242019-01-17 Eltrombopag in long‐term management of pediatric thrombocytopenia Shah, Sanjay J. Etzl, Michael M. Clin Case Rep Case Reports Eltrombopag is a thrombopoietin receptor agonist that may be effective in a broad range of thrombocytopenias of distinct etiology. We have observed rapid, robust, and sustained responses to eltrombopag in two young patients with refractory thrombocytopenia, one with primary immune thrombocytopenia and the other with Evans syndrome. John Wiley and Sons Inc. 2018-12-10 /pmc/articles/PMC6333124/ /pubmed/30656041 http://dx.doi.org/10.1002/ccr3.1916 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Shah, Sanjay J.
Etzl, Michael M.
Eltrombopag in long‐term management of pediatric thrombocytopenia
title Eltrombopag in long‐term management of pediatric thrombocytopenia
title_full Eltrombopag in long‐term management of pediatric thrombocytopenia
title_fullStr Eltrombopag in long‐term management of pediatric thrombocytopenia
title_full_unstemmed Eltrombopag in long‐term management of pediatric thrombocytopenia
title_short Eltrombopag in long‐term management of pediatric thrombocytopenia
title_sort eltrombopag in long‐term management of pediatric thrombocytopenia
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333124/
https://www.ncbi.nlm.nih.gov/pubmed/30656041
http://dx.doi.org/10.1002/ccr3.1916
work_keys_str_mv AT shahsanjayj eltrombopaginlongtermmanagementofpediatricthrombocytopenia
AT etzlmichaelm eltrombopaginlongtermmanagementofpediatricthrombocytopenia

Ejemplares similares